PTPRC and melanoma: While the total number of CD4+ T cells (CD45+ CD3+ CD4+) was not significantly different, that of CD4+ regulatory T cells (CD45+ CD3+ CD4+ FoxP3+) was significantly decreased in in AR-silenced YUMM1.7 melanomas (Fig. 10 H).